Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
Authors
Keywords
-
Journal
BRAIN
Volume 142, Issue 3, Pages 512-525
Publisher
Oxford University Press (OUP)
Online
2019-02-05
DOI
10.1093/brain/awz023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity
- (2018) Matthias Luz et al. ARCHIVES OF TOXICOLOGY
- Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models
- (2017) Xiaomin Su et al. MOLECULAR THERAPY
- Chronic, intermittent convection-enhanced delivery devices
- (2016) Owen Lewis et al. JOURNAL OF NEUROSCIENCE METHODS
- A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
- (2014) Neil U. Barua et al. DRUG DELIVERY
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- In vitro and in vivo testing of a novel recessed-step catheter for reflux-free convection-enhanced drug delivery to the brain
- (2013) T. Gill et al. JOURNAL OF NEUROSCIENCE METHODS
- Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port
- (2013) N.U. Barua et al. JOURNAL OF NEUROSCIENCE METHODS
- Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation
- (2013) N. K. Patel et al. NEUROLOGY
- GDNF, NGF and BDNF as therapeutic options for neurodegeneration
- (2013) Shelley J. Allen et al. PHARMACOLOGY & THERAPEUTICS
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
- (2012) M. Decressac et al. Science Translational Medicine
- GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
- (2011) M. Decressac et al. BRAIN
- The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery
- (2011) A. Bienemann et al. JOURNAL OF NEUROSCIENCE METHODS
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- Neuroimaging in Parkinson’s Disease
- (2011) A. Jon Stoessl Neurotherapeutics
- The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
- (2010) Lisa M. Shulman et al. ARCHIVES OF NEUROLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Image-guided convection-enhanced delivery of GDNF protein into monkey putamen
- (2010) Francisco Gimenez et al. NEUROIMAGE
- Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain
- (2010) Piotr Hadaczek et al. NEUROPHARMACOLOGY
- Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
- (2009) R. Nandhagopal et al. BRAIN
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More